Skip to main content
Clinical Trials/JPRN-UMIN000046310
JPRN-UMIN000046310
Recruiting
未知

A novel strategy for prevention of cognitive decline and stress care using a "smart healing space" that stimulates the five senses - An integrative medical approach based on co-creation between humans and the latest technology - A novel strategy for prevention of cognitive decline and stress care using a "healing smart space" that stimulates the five senses

Osaka Center for Cancer and Cardiovascular Disease Prevention0 sites60 target enrollmentDecember 7, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Mild cognitive impairment, behavior and psychological symptoms of dementia, stress
Sponsor
Osaka Center for Cancer and Cardiovascular Disease Prevention
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2021
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Under 20 years old. 2\.MMSE\-J score of 15 or less. 3\.Have a visual impairment that prevents recognition of images even when vision is corrected with glasses, etc. 4\.Have hearing impairment to the extent that they cannot hear sounds even with the use of hearing aids. 5\.Self\-reported susceptibility to motion sickness or VIMS. 6\.Has difficulty in sitting up. 7\.Cognitive function has declined to the extent that the patient is unable to answer the questionnaire (e.g., communication is not possible even with support when answering). 8\.Has started donepezil, rivastigmine, galantamine, or memantine within the last 3 months. 9\.Is judged by the principal investigator to be inappropriate for participation in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Postponing cognitive decline and preventing early unemployment in patients with multiple sclerosis - strengthening the brain and mind (part of the Don't be late! study)MSMultiple Sclerosis1000381610012303
NL-OMON53491Amsterdam UMC270
Active, not recruiting
Phase 1
Preventing Cognitive Decline and Dementia from Cerebral Small Vessel Diseaseacunar (small vessel) ischaemic strokeMedDRA version: 19.0 Level: LLT Classification code 10023987 Term: Late effects of cerebrovascular disease System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: LLT Classification code 10042244 Term: Stroke System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: PT Classification code 10068644 Term: Brain stem stroke System Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0 Level: PT Classification code 10071043 Term: Basal ganglia stroke System Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2015-001953-33-GBniversity of Edinburgh60
Active, not recruiting
Phase 1
Towards Onset Prevention of COGnitive decline in adults with Down syndrome (the TOP-COG study) - The TOP-COG studyAlzheimer's disease Down syndromeMedDRA version: 14.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.0 Level: LLT Classification code 10013616 Term: Down's syndrome System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
EUCTR2011-001564-21-GBHS Greater Glasgow and Clyde70
Completed
Not Applicable
Interventions to Attenuate Cognitive Decline: Keys to Staying SharpMild Cognitive ImpairmentAge-related Cognitive Decline
NCT03528486University of South Florida268
Unknown
Not Applicable
Multiple Interventions to Prevent Cognitive DeclineCognitive DysfunctionCognition DisordersMemory Disorders
NCT04079075Universidade do Porto50